Advertisement
U.S. markets closed

Sartorius Stedim Biotech S.A. (DIM.PA)

Paris - Paris Delayed Price. Currency in EUR
188.80-3.60 (-1.87%)
At close: 04:35PM CET
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
2,735,500
2,775,500
3,492,700
2,887,000
1,910,081
-
Cost of Revenue
1,550,100
1,542,000
1,675,400
1,334,000
906,759
-
Gross Profit
1,185,400
1,233,500
1,817,400
1,553,000
1,003,323
-
Operating Expense
784,700
763,000
762,400
670,000
499,877
-
Operating Income
400,700
470,500
1,055,000
883,000
503,446
-
Net Non Operating Interest Income Expense
-229,500
-122,600
-9,700
-6,700
-12,098
-
Pretax Income
224,600
401,100
1,130,400
646,700
460,694
-
Tax Provision
59,900
89,000
250,500
232,400
122,095
-
Net Income Common Stockholders
160,600
309,700
876,100
414,400
335,932
-
Diluted NI Available to Com Stockholders
160,600
309,700
876,100
414,400
335,932
-
Basic EPS
5.00
3.36
9.51
4.50
3.64
-
Diluted EPS
5.00
3.36
9.51
4.50
3.64
-
Basic Average Shares
92,137
92,161
92,163
92,177
92,179
-
Diluted Average Shares
92,137
92,161
92,163
92,177
92,179
-
Total Operating Income as Reported
-
-
995,200
865,421
471,714
331,842
Total Expenses
2,334,800
2,305,000
2,437,800
2,004,000
1,406,636
-
Net Income from Continuing & Discontinued Operation
160,600
309,700
876,100
414,400
335,932
-
Normalized Income
116,382
262,787
777,761
567,279
359,145
-
Interest Income
-40,200
6,200
500
300
509
-
Interest Expense
177,500
117,000
18,600
10,400
6,819
-
Net Interest Income
-229,500
-122,600
-9,700
-6,700
-12,098
-
EBIT
402,100
518,100
1,149,000
657,100
467,513
-
EBITDA
697,400
755,700
1,330,700
798,700
569,200
-
Reconciled Cost of Revenue
1,550,100
1,542,000
1,675,400
1,334,000
906,759
-
Reconciled Depreciation
295,300
237,600
181,700
141,600
101,687
-
Net Income from Continuing Operation Net Minority Interest
160,600
309,700
876,100
414,400
335,932
-
Total Unusual Items Excluding Goodwill
60,300
60,300
126,400
-238,500
-31,582
-
Total Unusual Items
60,300
60,300
126,400
-238,500
-31,582
-
Normalized EBITDA
637,100
695,400
1,204,300
1,037,200
600,782
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
16,082
13,387
28,061
-85,621
-8,369
-